Skip to content

The correlation between microplastics exposure and male semen quality and the exploration research of biomarkers

The correlation between microplastics exposure and male semen quality and the exploration research of biomarkers

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070596
Enrollment
Unknown
Registered
2023-04-18
Start date
2023-04-18
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Infertility

Interventions

High MP exposure group (Male front-line workers with occupational exposure for more than 5 years in a plastic product factory):N/A
Medium MP exposure group (Ordinary working men who order takeout twice a week in ordinary cities):N/A
Low MP exposure group (Remote rural transportation is not convenient rural permanent male population):N/A

Sponsors

South China Hospital of Shenzhen University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Abstinence time, 2-7 days (2) Information on routine semen testing, completed questionnaires, and residual semen volume after routine semen testing were required to exceed the minimum requirements for microplastics testing. (3) Age range 18-45 years (4) No recent exposure to metallochemicals, no history of radiation. (5)Voluntarily signed informed consent and able to actively cooperate.

Exclusion criteria

Exclusion criteria: (1) Those whose questionnaire information was incomplete to fill in, more than 30% of the titles were either not filled in or did not respond to their title requirements; (2) Those suffering from reproductive diseases (azoospermia, cryptorchidism, epididymitis, prostatitis, sexually transmitted diseases, history of vasectomy, varicocele, etc.), birth defects (Y chromosome deletion; (3) Recent (within nearly 1 month) or long-term (3 consecutive months) intake of medications affecting semen quality (kidney tonic spermatogonia); (4) Affected with endocrinopathies, cardiovascular diseases). (5) Patients with comorbid cancer or hematological diseases; (6) Patients with combined hepatic and renal dysfunction; (7) Data on clinical cases, incomplete laboratory test results.

Design outcomes

Primary

MeasureTime frame
The routine examination of semen;Reactive Oxygen Species;Mitochondrial Membrane Potential;DNA Fragmentation Index;Microplastic concentrations in semen;Inflammatory cytokines;

Countries

China

Contacts

Public ContactNan Liu

South China Hospital of Shenzhen University

13688869875@163.com+86 13688869875

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026